Home > News > Biophan's Intellectual Property Portfolio Expands to 140
June 22nd, 2005
Biophan's Intellectual Property Portfolio Expands to 140
Abstract:
Biophan Technologies, Inc., a developer of next-generation medical technology, has announced further expansion of its intellectual property portfolio in recent weeks with 13 new applications filed - resulting in a 10% growth - to a total of 140 U.S. issued or pending patents, plus international patents.
Source:
businesswire
Related News Press |
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||